T1	Participants 72 103	esophageal carcinoma in Asians.
T2	Participants 270 285	in Asian people
T3	Participants 453 513	Patients of resectable esophageal cancer of comparable stage
T4	Participants 679 698	Discharged patients
T5	Participants 1125 1276	Up to December 2006, eighty-seven patients of stage II and III, including 71 patients of middle third lesions and 16 lower third lesions were enrolled.
